Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Deray

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculationLucile Mercadal, Sophie Tézenas Du Montcel, Marie-Chantal Jaudon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKDSophie Liabeuf, Jessica Berdougo-Tritz, Lucie Augey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in FranceCorinne Isnard Bagnis, Cécile Couchoud, Marc Bowens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIVHeidi Hannon, Corinne Isnard Bagnis, Yves Benhamou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyHassane Izzedine, Jean Sebastien Hulot, Daniel Vittecoq, et al.
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2004
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsVincent Launay-Vacher, Hassane Izzedine, Jean-Baptiste Rey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2013
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC surveyNicolas Janus, Florian Scotte, Jean-Baptiste Rey, et al.
Blood Purification|January 14, 2010
Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicinMarcia Venditto, Sophie Tezenas du Montcel, Jérôme Robert, et al.
Cancer|July 20, 2007
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) studyVincent Launay-Vacher, Stéphane Oudard, Nicolas Janus, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 5, 2002
Ionic dialysance vs urea clearance in the absence of cardiopulmonary recirculationLucile Mercadal, Sophie Tézenas Du Montcel, Marie-Chantal Jaudon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2025
QT-Prolonging Medications: Prevalence of Use and Associated Risks in CKDSophie Liabeuf, Jessica Berdougo-Tritz, Lucie Augey, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 21, 2017
Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in FranceCorinne Isnard Bagnis, Cécile Couchoud, Marc Bowens, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2004
The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIVHeidi Hannon, Corinne Isnard Bagnis, Yves Benhamou, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 2005
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre studyHassane Izzedine, Jean Sebastien Hulot, Daniel Vittecoq, et al.
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 29, 2004
Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsVincent Launay-Vacher, Hassane Izzedine, Jean-Baptiste Rey, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2013
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC surveyNicolas Janus, Florian Scotte, Jean-Baptiste Rey, et al.
Blood Purification|January 14, 2010
Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicinMarcia Venditto, Sophie Tezenas du Montcel, Jérôme Robert, et al.
Cancer|July 20, 2007
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) studyVincent Launay-Vacher, Stéphane Oudard, Nicolas Janus, et al.
Pageof 22